As Johnson & Johnson continues to move out of the diabetes business, the company has sold its Calibra product (marketed as OneTouch Via, but never launched) to CeQur, a 10-year-old company working on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results